Clinical Illness and Outcomes in Patients with Severe Community-Acquired Pneumonia: A Prospective StudyVijay Kumar Mittapally1* and Divya Lanka2
- Corresponding Author:
- Vijay Kumar Mittapally
Master of Sciences
Department of Biotechnology
Salem, Tamilnadu, India
E-mail: [email protected]
Received: 04/01/2015; Revised: 25/01/2015; Accepted: 02/02/2015
Purpose of review
Pneumonia is considered as the main lung infectious diseases cause for death and also the seventh leading cause for death overall within the United States. There is important interest in understanding the connection between community-acquired pneumonia (CAP) and mortality.
Pneumonia is that the seventh leading explanation for death in US. It’s calculable that there are four million cases of community-acquired pneumonia (CAP)/yr within the US that ends in close to ten million medico visits, one million hospitalizations, and 45,000 deaths. There are not any massive studies from Asian nation on incidence of CAP; but, mortality knowledge on total variety of deaths square measure obtainable associated with lower respiratory tract infection (LRTI). Variety of deaths owing to LRTI was 35.1/100,000 population in 2008 compared to 35.8/100,000 population for TB & deaths associated with gastro enteral infections & parasitic diseases was 194.9/100,000 population. As per the WHO knowledge overall mortality because of LRTI is around 20% in our country.
This review focuses on the latest literature assessing the importance and also the frequency of long associated outcomes in patients with CAP, the risk factors, and conceivable ramifications for future methods. Numerous danger elements that incorporate age, sex, comorbid conditions, kind of pneumonia, and seriousness of illness are connected with higher long-term mortality.